News summary
Jincheng pharmaceuticalonlinecasinowithfreesignupbonusrealmoney: Cefminox sodium obtained drug registration certificate Securities Times e Company NewsonlinecasinowithfreesignupbonusrealmoneyJincheng Pharmaceutical (300233) announced on the evening of April 29 that Guangdong Jincheng Jinsu Pharmaceutical Co., Ltd., the company's controlling subsidiary, recently received the registration of cefminox sodium for injection issued by the State Food and Drug Administrationonlinecasinowithfreesignupbonusrealmoney.onlinecasinowithfreesignupbonusrealmoney..
Newsletter text
Jincheng Pharmaceutical: Cefminox sodium obtained drug registration certificate Securities Times e Company News, Jincheng Pharmaceutical (300233) announced on the evening of April 29 that Guangdong Jincheng Jinsu Pharmaceutical Co., Ltd., the company's holding subsidiary, recently received the State Drug Administration issued the registration certificate of cefminox sodium for injection. Cefminox sodium is mainly used to treat some infections caused by sensitive Streptococcus spp., Streptococcus pneumoniae, etc.
